So near yet so far: why won’t the UK prescribe medical cannabis?

This viewpoint describes the series of distinct barriers to prescribing medical cannabis, including the perceived lack of randomised controlled trial evidence; which authors state need to be overcome in order to improve patient access in the UK.

BMJ Open